• Z-IETD-FMK: Specific Caspase-8 Inhibitor for Apoptosis Resea

  2026-05-03

  Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) is a potent, selective inhibitor of caspase-8, central to apoptosis and T cell activation studies. Its irreversible mechanism enables precise modulation of cell death pathways without affecting resting immune cells. APExBIO provides validated protocols for research use, supporting advanced immune cell signaling and apoptosis research with robust benchmarks.

• HLTP1 Peptide Attenuates Hepatic Ischemia-Reperfusion Injury

  2026-05-02

  This study identifies a novel human-derived peptide, HLTP1, that significantly reduces hepatic ischemia-reperfusion injury (HIRI) by inhibiting Jun N-terminal kinase (JNK) phosphorylation and apoptosis in experimental models. The findings offer mechanistic insight and a promising foundation for therapeutic strategies targeting liver transplant complications.

• Dual SMAD/Wnt Inhibition Enables Efficient iPSC-RGC Differen

  2026-05-02

  This study introduces a chemically defined protocol for efficiently differentiating human induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) by dual inhibition of SMAD and Wnt pathways. The method achieves high purity and reproducibility without genetic manipulation, offering a robust platform for modeling glaucoma and advancing neurodegenerative disease research.

• Ionomycin Calcium Salt: Precision Calcium Ionophore for Canc

  2026-05-01

  Ionomycin calcium salt empowers researchers with unrivaled control over intracellular Ca2+ flux, enabling high-fidelity modeling of calcium-dependent cell signaling and apoptosis. Its validated anti-cancer actions, especially in bladder cancer models, set it apart as a gold-standard calcium ionophore for translational and mechanistic workflows.

• Multi-Omics Reveals ARID1A-Driven Resistance in Melanoma

  2026-04-30

  This study employs integrative multi-omics to dissect early and acquired resistance mechanisms to BRAF/MAPK inhibition in melanoma, focusing on the role of ARID1A loss. The findings highlight key signaling nodes and transcriptional rewiring underpinning resistance, offering new targets for research into more durable melanoma therapies.

• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-04-30

  Harper et al. (2025) demonstrate that inhibition of RNA polymerase II (Pol II) induces apoptosis through an active signaling pathway, independent of global transcriptional shutdown. This finding redefines cell death mechanisms in response to transcriptional stress and offers new experimental avenues for apoptosis and inflammation research.

• Tunicamycin as a Molecular Probe: Decoding ER Stress Pathway

  2026-04-29

  Explore how Tunicamycin, a potent N-glycosylation inhibitor, is illuminating new frontiers in ER stress pathway research and inflammation suppression. Distinct from protocol-driven guides, this article delivers a mechanistic, cross-disciplinary analysis with practical assay insights.

• Annexin V, Human Recombinant: Advanced Strategies for High-P

  2026-04-29

  Discover how Annexin V, a premier phosphatidylserine binding protein, enables high-precision apoptosis detection and advanced cell death research. This article uniquely explores its mechanistic depth, protocol optimization, and translational impact in oncology.

• Dihydroartemisinin: Applied Protocols in mTOR & Malaria Rese

  2026-04-28

  Dihydroartemisinin, derived from Artemisia plant extract, empowers advanced research in mTOR signaling and antimalarial assays with precision and reproducibility. This guide delivers stepwise experimental workflows, troubleshooting strategies, and actionable insights for maximizing the scientific impact of this potent agent from APExBIO.

• Kanamycin Sulfate: Mechanistic Insight and Translational Imp

  2026-04-28

  Explore the mechanistic precision and strategic utility of Kanamycin Sulfate in translational research. This article blends biological rationale, competitive evidence, and actionable guidance to empower robust microbiology and antibiotic resistance studies, showcasing how APExBIO’s high-purity Kanamycin Sulfate stands apart in supporting modern workflows.

• Patient-Derived 3D Spheroid Models Advance Prostate Cancer R

  2026-04-27

  This study establishes robust patient-derived 3D spheroid cultures from radical prostatectomy samples as physiologically relevant models of organ-confined prostate cancer. The work demonstrates their viability for long-term culture, preservation, and drug response profiling, offering a translational bridge between clinical specimens and experimental therapeutics.

• Applied Workflows with Enhanced ECL Chemiluminescent Detecti

  2026-04-27

  Unlock ultra-sensitive western blot protein quantification with the Enhanced ECL Chemiluminescent Substrate Detection Kit. APExBIO's solution offers unmatched sensitivity, streamlined protocols, and robust performance for antibody detection assays—even in demanding resistance mechanism studies.

• Firefly Luciferase mRNA: Optimized 5-moUTP Reporter Workflow

  2026-04-26

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) accelerates robust gene expression assays by combining advanced immune evasion with exceptional mRNA stability. Unlock reproducible, high-sensitivity bioluminescent reporting for cell-based and in vivo applications, leveraging breakthroughs in mRNA delivery and workflow optimization.

• SR-202 in Insulin Resistance & Obesity Research: Protocols &

  2026-04-25

  SR-202, a selective PPARγ antagonist, is reshaping workflows in insulin resistance and obesity research by enabling precise dissection of adipogenesis and immunometabolic signaling. This guide delivers actionable protocols, troubleshooting strategies, and translational insights for deploying SR-202 in advanced metabolic and immune studies.

• Penicillin G Sodium: Optimized Protocols for Reliable Bacter

  2026-04-24

  Penicillin G Sodium from APExBIO sets the benchmark for reproducible, high-fidelity Gram-positive bacterial control in both research and clinical workflows. This guide delivers actionable protocol enhancements, troubleshooting strategies, and cross-study insights to maximize the antibiotic’s value in contamination prevention and experimental design.

443 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page